Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2008-6-13
pubmed:abstractText
Pheochromocytomas are malignant in approximately 10% of patients. The histologic differentiation between benign and malignant tumors is difficult, the latter diagnosed by the presence of metastatic disease or recurrence.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1532-7361
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
143
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
759-68
pubmed:meshHeading
pubmed-meshheading:18549892-Adolescent, pubmed-meshheading:18549892-Adrenal Gland Neoplasms, pubmed-meshheading:18549892-Adult, pubmed-meshheading:18549892-Aged, pubmed-meshheading:18549892-Apoptosis, pubmed-meshheading:18549892-Cell Cycle, pubmed-meshheading:18549892-Diagnosis, Differential, pubmed-meshheading:18549892-Female, pubmed-meshheading:18549892-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18549892-Humans, pubmed-meshheading:18549892-Ki-67 Antigen, pubmed-meshheading:18549892-Male, pubmed-meshheading:18549892-Middle Aged, pubmed-meshheading:18549892-Necrosis, pubmed-meshheading:18549892-Neoplasm Recurrence, Local, pubmed-meshheading:18549892-Pheochromocytoma, pubmed-meshheading:18549892-Predictive Value of Tests, pubmed-meshheading:18549892-Prognosis, pubmed-meshheading:18549892-Prospective Studies, pubmed-meshheading:18549892-Risk Factors, pubmed-meshheading:18549892-Severity of Illness Index, pubmed-meshheading:18549892-Single-Blind Method, pubmed-meshheading:18549892-Tumor Markers, Biological
pubmed:year
2008
pubmed:articleTitle
Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
pubmed:affiliation
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
pubmed:publicationType
Journal Article, Clinical Trial